Top 45 Life Science Startup Investors in Oceania (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Main Sequence Ventures
VC Fund
|
3 | Australia, United States, Philippines | Seed, Series A, Series B | Software, Artificial Intelligence, Manufacturing | $1M–$72M |
|
New Zealand Green Investment Finance
VC Fund
|
3 | New Zealand, Australia, United Kingdom | Debt Financing, Seed, Venture - Series Unknown | Energy, Renewable Energy, Solar | $372k–$49M |
|
Catalio Capital Management
VC Fund
|
2 | United States, Switzerland, Israel | Series A, Series B | Biotechnology, Health Care, Life Science | $15M–$150M |
|
Tin Alley Ventures
VC Fund
|
2 | Australia, Philippines | Pre-Seed, Seed, Series B | Biotechnology, Medical, Software | $430k–$2.9M |
|
Brandon Capital
VC Fund
|
2 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$81M |
|
AgriZeroNZ
VC Fund
|
2 | United States, New Zealand, Sweden | Seed, Series A, Venture - Series Unknown | Biotechnology, AgTech, Animal Feed | $677k–$27M |
|
Finistere Ventures
VC Fund
|
1 | United States, New Zealand, Israel | Series B, Series C, Series A | Biotechnology, Agriculture, Food and Beverage | $3.5M–$45M |
|
OurCrowd
VC Fund
|
1 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $593k–$65M |
|
Digitalis Ventures
VC Fund
|
1 | United States, United Kingdom, China | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $1.5M–$132M |
|
Regeneration.VC
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series A, Seed, Series B | Manufacturing, Fashion, Software | $2.1M–$30M |
|
Centre for Climate Action Joint Venture
VC Fund
|
1 | New Zealand | Seed | Life Science, Biotechnology | |
|
Time Ventures
VC Fund
|
1 | United States, Canada, Germany | Series A, Series B, Seed | Software, Information Technology, Artificial Intelligence | $3.1M–$450M |
|
Cultivate Ventures
VC Fund
|
1 | New Zealand, United States | Seed, Series A | Biotechnology, Sensor, Farming | $3M–$9.6M |
|
Accelerating Commercialisation - AusIndustry
VC Fund
|
1 | Australia | Grant, Pre-Seed | Software, SaaS, AgTech | $153k–$472k |
|
Benny Kleist
Angel
|
1 | Australia, New Zealand | Pre-Seed, Series A | Education, E-Learning, Life Science | |
|
Flintco, LLC
VC Fund
|
1 | Australia | Seed | Real Estate, Life Science, Property Management | |
|
Rosrain Investments
VC Fund
|
1 | New Zealand | Series A | Life Science, Biotechnology | |
|
AbbVie Biotech Ventures
VC Fund
|
1 | United States, China, Italy | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6M–$115M |
|
HOF Capital
VC Fund
|
1 | United States, United Kingdom, Singapore | Seed, Series A, Series B | Artificial Intelligence, Financial Services, FinTech | $850k–$863M |
|
Marex
VC Fund
|
1 | Canada, New Zealand, United States | Corporate Round, Series A | Financial Services, Finance, Lending | |
|
Alium Capital
VC Fund
|
1 | Australia, United States, Hong Kong | Series A, Series B, Seed | Software, FinTech, Financial Services | $500k–$465M |
|
Possible Ventures
VC Fund
|
1 | Germany, United States, Australia | Seed, Pre-Seed, Series A | Software, Biotechnology, Information Technology | $586k–$47M |
|
ONE Innovators
VC Fund
|
1 | Japan, Australia | Series B, Seed, Series A | AgTech, Sensor, Farming | |
|
Annie Hill
Angel
|
1 | Australia | Seed | Aquaculture, Life Science, Biotechnology | |
|
Antler
VC Fund
|
1 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $70k–$15M |
|
Fonterra Co-operative Group
VC Fund
|
1 | New Zealand, United States, Germany | Seed, Pre-Seed, Series B | Biotechnology, Food and Beverage, Wellness | $151k–$17M |
|
Matū Group
VC Fund
|
1 | New Zealand, Australia, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Manufacturing | $337k–$25M |
|
Harry Debney
Angel
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Dennis Mehiel
Angel
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
The March Group
VC Fund
|
1 | United States, Denmark, Australia | Series A, Seed, Series C | Biotechnology, SaaS, AgTech | $4.7M–$33M |
|
Churchill Asset Management
VC Fund
|
1 | United States, Canada, Australia | Debt Financing, Private Equity, Series A | Health Care, Manufacturing, Food and Beverage | |
|
Riverlane Capital
VC Fund
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Icehouse Ventures
VC Fund
|
1 | New Zealand, United States, United Kingdom | Seed, Series A | Software, SaaS, Information Technology | $650k–$19M |
|
Breakthrough Victoria
VC Fund
|
1 | Australia, United States, Philippines | Seed, Venture - Series Unknown, Series A | Health Care, Manufacturing, Biotechnology | $500k–$35M |
|
Uniseed Ventures
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed | Biotechnology, Health Care, Manufacturing | $381k–$16M |
|
Callaghan Innovation
VC Fund
|
1 | New Zealand, Australia, United States | Grant, Seed, Pre-Seed | Manufacturing, Software, Information Technology | $5.7k–$1M |
|
Powerhouse Ventures
VC Fund
|
1 | New Zealand, United States, France | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Manufacturing | $255k–$8M |
|
Massey Ventures
VC Fund
|
1 | New Zealand | Seed, Pre-Seed | Genetics, Horticulture, Life Science | |
|
Skalata
VC Fund
|
1 | Australia, United States, United Kingdom | Pre-Seed, Seed | Software, Information Technology, Artificial Intelligence | $125k–$2.3M |
|
OneVentures
VC Fund
|
1 | Australia, United States, Israel | Series A, Debt Financing | Software, Health Care, Biotechnology | $1M–$20M |
|
Third Hemisphere
VC Fund
|
1 | Australia | Seed | Aquaculture, Life Science, Biotechnology | |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $1.3M–$16M |
|
Paul Little’s family office
VC Fund
|
1 | Australia | Seed, Series A | E-Commerce, Real Estate, Life Science | |
|
Parkview International
VC Fund
|
1 | Australia, United States | Series A, Series C | Pet, Medical, Veterinary | |
| Access all 45 investors in Oceania Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Manufacturing
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 130
- Round size: Seed $1M–$7M; Series A $4.5M–$30M; Series B $13M–$72M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $303M in 2023
Portfolio highlights
- Varden — FILM-FREE BARRIER COATING
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
New Zealand Green Investment Finance provides support to the growth of innovative energy and carbon management.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Solar
- Stage:Debt Financing, Seed, Venture - Series Unknown
- Geography: New Zealand, Australia, United Kingdom
Investor stats
- Total investments: 29
- Round size: Seed $3.1M–$7.6M; Debt Financing $644k–$49M; Venture - Series Unknown $372k–$3.2M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- ESP — ESP is an energy solution provider.
- Carbn Group — Carbn Group is a car fleet management company that makes car fleet services sustainable and accessible to more users.
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: United States, Switzerland, Israel
Investor stats
- Total investments: 142
- Round size: Series A $15M–$150M; Series B $26M–$130M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- OSPRI — Multiplex qPCR reagent kits for assay development, biomarker discovery, and translational research. 120+ configurations across a broad range of research areas. Extraction-free. Customizable. For Research Use Only.
- Ratio Therapeutics — Ratio is a privately held discovery-stage biotechnology company that utilizes a suite of technologies licensed from Cornell University to develop best-in-class targeted radiotherapeutics for the treatment of metastatic cancers.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Pre-Seed, Seed, Series B
- Geography: Australia, Philippines
Investor stats
- Total investments: 7
- Round size: Pre-Seed $430k–$2.9M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- i14 — We are i14 — we sit at the intersection of Computational Cognitive Science and AI research, and have developed a new class of models called Laplace Sequence Models that are an order of magnitude faster and more efficient and multiples more accurate than the transformer. We’ve also built a foundation model platform that allows organisations tocreate private, domain-specific expert models deployable across any environment (on-prem, at the edge, on device, in a private cloud, or hosted by i14). Our research lab continues to push beyond many of the limitations of current AI, and has a host of research projects which are continually integrated to update our foundation model platform. We recently closed a $4M initial round and are preparing for the next round.
- Mirugen — Mirugen is a preclinical biotechnology company (re)programming cells to unlock innate cellular repair mechanisms.
- Kronus — Full-stack development infrastructure for safety-critical systems.
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 79
- Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Series B $6.4M–$68M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- Longas — Longas Technologies, a Next Generation Sequencing (NGS) technology developer, has provided details on its Morphoseq™ library prep and associated software technology at the ‘Sequencing, Finishing and Analysis.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Cincera Therapeutics — Cincera Therapeutics is a privately held biotechnology company.
A world-first public-private partnership helping farmers reduce emissions while maintaining profitability and productivity.
Show more...Investment focus
- Industry: Biotechnology, AgTech, Animal Feed
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, New Zealand, Sweden
Investor stats
- Total investments: 16
- Round size: Seed $677k–$10M; Series A $7M–$27M; Venture - Series Unknown $3M–$14M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Rumin8 — Rumin8 - Solving livestock methane emissions
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
- Āmua Innovation — Āmua Innovation specializes in developing solutions for pasture-based farming to lead natural food production.
Finistere Ventures is an agricultural technology and life sciences venture capital investor. Founded in 2005, the company partners with other entrepreneurs and creative thinkers to build innovative companies that have the potential to transform modern agriculture, increase food security, improve nutrition, and enhance sustainability. Their appliedexperience as operators, and pioneering role in Ag Tech, is actively utilized to benefit its portfolio companies and Partners. Finistere has global access to the best new technologies from centers of Ag Tech excellence in the U.S., Australia, Israel, New Zealand, and Canada through its venture partner networks. Finistere’s locations in San Diego and Palo Alto, California keeps them connected to the centers of mainstream venture investment and the world’s leading innovation ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Agriculture, Food and Beverage
- Stage:Series B, Series C, Series A
- Geography: United States, New Zealand, Israel
Investor stats
- Total investments: 67
- Round size: Series A $3.5M–$10M; Series B $7.5M–$45M; Series C $5M–$43M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $28M in 2021
Portfolio highlights
- POP — Strengthen your dog's immunity with Pop-Topper. Developed with top animal scientists and food innovators, our formulas leverage clinically proven superfoods to reduce inflammation and promote longevity. Backed by science, our daily meal topper seamlessly integrates into your dog's routine for optimal health benefits.
- Animol Discovery — Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.
- Berkeley Yeast — Better yeast for better beer. Make cleaner tasting beer with ultra low diacetyl strains, brew non alcoholic beer that tastes more like actual beer, or unlock bright grapefruit and passionfruit notes with the cleanest thiol yeast.
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 309
- Round size: Seed $593k–$10M; Series A $5.3M–$34M; Series B $8M–$65M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
- MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Engineering solutions to complex problems in health through venture investment and company creation.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 113
- Round size: Seed $1.5M–$15M; Series A $8.6M–$66M; Series B $13M–$132M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Somatix — A fully comprehensive monitoring solution with unique smartband technology. Solutions for SNFs, senior living, healthcare systems, and smoking cessation.
- Girihlet — Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies. Girihlet currently specializes in inexpensively sequencing and analyzing mtDNA and T cell receptors using novel, bias-free methods in order to harness their power as biomarkers for diagnostics in a variety of disorders.
- Omni — Omni provides Healthy Vegan Dog Food in the UK, made by vets to be a nutritionally complete meal for your dog. Feed your dog all the goodness of plants backed by science.
Founded in Los Angeles, Regeneration.VC is an early-stage venture fund supercharging consumer-powered climate innovation driven by circular and regenerative principles. Our investment strategy encompasses design (materials & packaging), use (consumer brands & products), and reuse technologies (reverse logistics & marketplaces) thatgenerate measurable environmental impact alongside outsized return potential.
Show more...Investment focus
- Industry: Manufacturing, Fashion, Software
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 24
- Round size: Seed $2.1M–$7.6M; Series A $5.6M–$30M; Series B $18M–$23M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $45M in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Hullbot — Hullbot offers an autonomous, frequent cleaning service for vessel hulls and propellers using specialized underwater robotics technology. This proactive cleaning prevents biofouling buildup, which reduces drag and results in fuel savings and increased fleet performance for operators. The robotics system is designed to work with all hull coatingsand provides routine inspections, asset intelligence, and real-time analytics on vessel performance without requiring divers.
- Colorifix — Colorifix is a biotechnology company that has pioneered the first entirely biological process to produce, deposit and fix pigments onto textiles. Using a synthetic biology approach, it offers a radically different solution to incumbent dyeing technologies that entirely cuts out the use of harsh chemistry and leads to huge reductions in waterconsumption. Colorifix’s investors include Cambridge Enterprise, H&M, Mills Fabrica, Primera Impact and Sagana, whose collective backing is funding its expansion. For more information, visit www.colorifix.com
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Centre for Climate Action Joint Venture focuses on investment and effort in tackling New Zealand’s Agricultural emissions to meet reduction targets
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Time Ventures is an investment fund for Marc Benioff. The company looks to invest in theB2B, hospitality, non-financial services, and commercial products and services sectors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 57
- Round size: Seed $3.1M–$450M; Series A $10M–$80M; Series B $20M–$140M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Laurel — Time by Ping frees lawyers from timekeeping so they can focus on their work, and firms can understand where time is being spent.
- June.ai — Discover June, a digital communication hub that replaces your email experience. June creates a new world for your existing email that gives you more control, interactivity and efficiency.
- June — Transform enterprise system deployment with June. AI-driven implementation for Salesforce, Snowflake, SAP & more. No downtime, faster delivery, full control.
Cultivate Ventures is an investment and advisory firm built to catalyze growth for promising food, wellness and fitness companies. We focus specifically on investment, business concept incubation, seed-to-growth stage acceleration and turn around advisory services. We believe strongly in strong returns on capital combined with collaboration,transparency, conscious consumerism. We take a long-term, collaborative and flexible approach to each company and client we work with and invest in, allowing our financial and operational stake to grow as our partners grow.
Show more...Investment focus
- Industry: Biotechnology, Sensor, Farming
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 5
- Round size: Seed $3M–$7M; Series A $7.3M–$9.6M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Hectre — Award winning, simple to use orchard apps for performance and cost management optimization.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
A grant program offered by AusIndustry as part of the Australian Government’s National Innovation and Science Agenda
Show more...Investment focus
- Industry: Software, SaaS, AgTech
- Stage:Grant, Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 6
- Round size: Grant $153k–$472k
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Getmee — Getmee AI is the leading AI-powered coaching app for communication and employability. We help you improve your English, soft skills, and interview confidence!
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
Benny Kleist is a Founder & COO of Eucalyptus.He attended The University of Queensland.
Show more...Investment focus
- Industry: Education, E-Learning, Life Science
- Stage:Pre-Seed, Series A
- Geography: Australia, New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
- NextWork — Building the best online learning experience to switch careers and upskill. Join the waitlist today, we are waiting for you!
Flintco provides innovative construction solutions with an unrelenting focus on quality, safety, cost and schedule.
Show more...Investment focus
- Industry: Real Estate, Life Science, Property Management
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LCG Capital Management — LCG Capital Management is a full-service commercial real estate firm providing integrated solutions across the real estate lifecycle.
Rosrain Investments is an investment firm.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, Italy
Investor stats
- Total investments: 49
- Round size: Series A $6M–$53M; Series B $12M–$85M; Series C $39M–$115M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Mozart Therapeutics — The company intended to focus on developing novel immune engagers.
- Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
HOF Capital is a global technology investment firm that leverages its global limited partner network to help founders build massive businesses.
Show more...Investment focus
- Industry: Artificial Intelligence, Financial Services, FinTech
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 229
- Round size: Seed $850k–$14M; Series A $10M–$52M; Series B $20M–$863M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $300M in 2022
Portfolio highlights
- Jota — Jota: The platform handles finances for individual entrepreneurs and business owners by allowing them to instantly pay, collect receivables, and manage their day-to-day operations with voice notes, text messages, and images through an AI-first chat conversation. All tasks are free and executed in seconds. Designed to save time and money, Jotaempowers its clients to focus on what truly matters to them.
- Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
- Valar Atomics — Valar Atomics is scaling nuclear energy for heavy industrial power and clean hydrocarbon fuel production.
Marex.com is a provider of business-to-business e-commerce solutions for the marine industry offers a proprietary set of procurement solutions.
Show more...Investment focus
- Industry: Financial Services, Finance, Lending
- Stage:Corporate Round, Series A
- Geography: Canada, New Zealand, United States
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
- Key Carbon — Carbon Neutral Royalty operates a permanent capital vehicle designed to finance projects in the Voluntary Carbon Markets (VCM) through a prepayment in exchange for a portion of future carbon credits. The company specializes in financial support for the project and sells carbon credits to corporations that have made net zero pledges to help themmeet their climate, biodiversity, and community commitments.Carbon Neutral Royalty was established in July, 2021 in Vancouver, British Columbia.
- Digital Prime Technologies — Full-Service Institutional-Grade Prime Brokerage for Digital Asset Management. DLCC offers full-service Prime Brokerage solutions for digital assets. Our all-in-one user interface leverages both API and Saas product offerings to connect clients with a growing network of liquidity providers to transact, borrow, and lend digital assets, and managecollateral. Our product suite also offers traditional Prime Brokerage services, such as consultation and capital introduction.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Alium Capital focuses on listed and unlisted technology investments to generate out-sized returns. The company invests in technology, innovation, and early-stage businesses, all the way through to publicly listed assets. It specializes in the fields of finance, investing, innovation, and capital.Alium Capital was founded in 2016 andheadquartered in Sydney, New South Wales.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series A, Series B, Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 45
- Round size: Seed $4.5M–$10M; Series A $500k–$13M; Series B $2M–$465M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $72M in 2017
Portfolio highlights
- Boost Lab — Boost Lab provides solutions for skincare products that are cost-effective, effective, and safe.
- Koala — We're simplifying the mattress and furniture game. With free & fast delivery and a 120 night risk-free trial Australia-wide, try it out online today.
- York Street Brands — York Street Brands, formed by the merger of Boost Lab and tbh Skincare specializes in serums that target a range of skin concerns.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United States, Australia
Investor stats
- Total investments: 170
- Round size: Seed $1.5M–$10M; Pre-Seed $586k–$3.5M; Series A $9.7M–$47M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Mkind — Mkind builds intelligent robots for high-mix manufacturing, developing advanced automation solutions that can adapt to diverse production requirements, improve operational efficiency, and support manufacturers in handling complex, low-volume, and frequently changing product lines.
- Orbem — Transform biological imaging with AI-powered MRI technology. Non-invasive solutions for poultry, fruits, nuts, and health. Building a sustainable future.
- Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
The global imperative of achieving net-zero emissions by 2050 demands innovative solutions across all nations, including Japan. Recognizing this urgency, ONE Innovators has established a dedicated venture capital fund focused on the carbon-neutral sector.
Show more...Investment focus
- Industry: AgTech, Sensor, Farming
- Stage:Series B, Seed, Series A
- Geography: Japan, Australia
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Archeda — Archeda is an IT firm that analysis of natural environments using remote sensing data.
- Creattura — Creatura assists companies in reducing greenhouse gas emissions by generating and distributing carbon credits and promoting the adoption of renewable energy sources.
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
Annie Hill
Show more...Investment focus
- Industry: Aquaculture, Life Science, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Fremantle Seaweed — Fremantle Seaweed is committed to combating climate change by growing Asparagopsis along with a variety of other local seaweeds ocean grown in local Western Australia waters.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 2214
- Round size: Seed $159k–$4.6M; Pre-Seed $100k–$645k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $72M in 2024
Portfolio highlights
- iiba — Iiba is a geospatial platform that specializes in providing location information related to child-rearing.
- Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
- Homethings — Single-use plastic is bonkers. Homethings makes cleaning products that make sense. No more shipping water in plastic bottles. We send non toxic cleaning tabs so that you can refill over and over again using your tap.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 407
- Round size: Seed $101k–$5M; Pre-Seed $70k–$1M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- LivedCX® — LIVEDCX: Advanced AI technology for contact centre leaders who must simplify complexity to create growth.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
We're a global dairy nutrition company owned by 10,000 farmers and their families, united by a fundamental belief in the power of dairy to make a difference.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Wellness
- Stage:Seed, Pre-Seed, Series B
- Geography: New Zealand, United States, Germany
Investor stats
- Total investments: 16
- Round size: Seed $581k–$724k; Pre-Seed $151k–$612k; Series B $10M–$17M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Vivici — Our mission is to meet the world's growing need for sustainable, nutritious and great tasting animal-free proteins.
- DNAiTECH — At DNAiTECH we develop innovative portable isothermal amplification instruments for point of care diagnostics, in-field applications, and rapid DNA testing.
- POP — Strengthen your dog's immunity with Pop-Topper. Developed with top animal scientists and food innovators, our formulas leverage clinically proven superfoods to reduce inflammation and promote longevity. Backed by science, our daily meal topper seamlessly integrates into your dog's routine for optimal health benefits.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 20
- Round size: Seed $473k–$2.2M; Pre-Seed $337k–$972k; Series A $2.3M–$25M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Advemto — Advemto is the manufacturer and developer of ultrafast spectroscopy systems that help researchers.
- Inhibit Coatings — Inhibit Coatings is a New Zealand based company developing novel antimicrobial and antifouling coatings.
- Captivate Technology — Captivate Technology company operates a clean-tech carbon capture platform. The platform enables cement manufacturers, geothermal power plants, and biogas producers to reduce pollution and contribute to environmental initiatives by using a metal-organic framework for CO2 adsorption as a solid-state material.
CEO @ Costa Group
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Dennis Mehiel is an American entrepreneur and investor, best known as the founder of Box USA. He has held leadership roles across business and public policy organizations and serves on the Board of Directors of the American Security Project.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A venture capital fund platform committed to supporting and investing in entrepreneurs and companies developing and bringing exponential technologies to food, health and sustainability. March's investment strategy involves becoming recognized as the leading investor in critical and transformative technology solutions, and aims to achieve thisby investing into companies and funds that focus on developing core intellectual property around game-changing sustainable solutions that are aligned with globally relevant sustainability trends and benefits.
Show more...Investment focus
- Industry: Biotechnology, SaaS, AgTech
- Stage:Series A, Seed, Series C
- Geography: United States, Denmark, Australia
Investor stats
- Total investments: 7
- Round size: Seed $4.7M–$4.8M; Series A $7.2M–$33M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $2.1M in 2019
Portfolio highlights
- Digestiva — We amplifye Protein.
- EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
Churchill is a leading capital provider for private equity-owned, middle market companies. We provide first lien, unitranche, second lien and mezzanine debt, in addition to equity co-investments, secondary solutions and private equity fund commitments.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Food and Beverage
- Stage:Debt Financing, Private Equity, Series A
- Geography: United States, Canada, Australia
Investor stats
- Total investments: 33
- Lead/follow: 9% lead, 91% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- One Physics — Apex Physics Partners serves medical centers and physics practices by offering therapy and diagnostic services and support for medical physics practices.
- Action Behavior Centers — Action Behavior Centers is a center-based provider of ABA therapy for children on the moderate to severe end of the autism spectrum.
- Choice Insurance Agency — Choice Insurance offers insurance solutions for your home, auto, business, and life. Discover how we can help to safeguard your financial future. Call Us.
Long-term owner-operators of great Australian businesses.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 252
- Round size: Seed $650k–$4.9M; Series A $2.5M–$19M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $69M in 2021
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 55
- Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
- Mental Jam — We are a games studio dedicated to creating impactful experiences that explore mental health.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Callaghan Innovation is a stand-alone Crown Entity established on 1 February, 2013. Their role hasn’t previously existed in New Zealand.When they succeed, all New Zealanders will benefit from a stronger economy, higher value exports, more productive and sustainable resource use, more jobs and higher incomes.International evidence showsadvanced technology institutes like Callaghan Innovation have been successful at helping businesses build innovation capability that contributes to their growth and the broader economy.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Grant, Seed, Pre-Seed
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 1834
- Round size: Seed $581k–$1M; Grant $5.7k–$98k; Pre-Seed $607k–$716k
- Lead/follow: 99% lead, 1% follow
Portfolio highlights
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
- Wallo Pay — Wallo Pay, incorporated in July 2023, is a New Zealand-based fintech startup transforming digital payments for consumers and businesses. Operating across Aotearoa and with plans to expand into Australia, our founder-led team is building a B2C and B2B payments platform powered by banking APIs, enabling direct, real-time account-to-accounttransactions. By bypassing traditional card networks, Wallo Pay slashes merchant service fees from 1.5–2.5% to 0.6% or less, potentially saving New Zealand businesses $700M annually. Our product suite includes a Consumer Mobile App with QR-based and unique digital ID based payments, a Business Mobile App, and a Business Web Portal, targeting retail, hospitality, and other businesses accepting payments from end customers.Aligned with New Zealand’s Consumer Data Right (2025), Wallo Pay’s open API infrastructure empowers developers, fintech startups, and public agencies to build innovative solutions, from loyalty programs to interoperable transport payments. Our platform fosters an inclusive ecosystem, enabling business of all sizes and innovators to participate in the digital economy with low-cost, scalable payment tools. Since starting MVP development in June 2024, Wallo Pay is gearing up for an alpha pilot in Q3–Q4 2025, driving transparency, affordability, and trust in Aotearoa’s payment landscape.
- Forever Harvest — We are an Aotearoa New Zealand based cellular horticulture company, partnering with food & beverage manufacturers to develop new fruit & nut food solutions.
powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: New Zealand, United States, France
Investor stats
- Total investments: 12
- Round size: Seed $2.1M–$7.9M; Series A $255k–$7M; Venture - Series Unknown $921k–$8M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- VeriQuantix — VeriQuantix was spun out of the University of Queensland. VeriQuantix is an Australian startup specializing in cybersecurity, focusing on quantum technology to enhance the security of optical fiber communication networks. Their core innovation, Quantum Link Verification (QLV), is designed to detect and alert network operators to physical tappingattempts and intercept cyber attacks on fiber optic networks. This technology leverages quantum principles, specifically entangled photons, to verify the trustworthiness of network links by ensuring that any unauthorized access disrupts photon entanglement and triggers immediate alerts.
- Granular Energy — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
- Liquid Instruments — Redefining the way scientists, engineers, students, and professionals experience test and measurement with Moku software-reconfigurable hardware platforms
Massey Ventures supports the development of commercially promising ideas by providing early stage investment. The firm commercializes intellectual property and innovative research. The company guides Massey researchers and students through the commercialisation process in order to make their innovative ideas a reality.
Show more...Investment focus
- Industry: Genetics, Horticulture, Life Science
- Stage:Seed, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Captivate Technology — Captivate Technology company operates a clean-tech carbon capture platform. The platform enables cement manufacturers, geothermal power plants, and biogas producers to reduce pollution and contribute to environmental initiatives by using a metal-organic framework for CO2 adsorption as a solid-state material.
- Ampersand Technologies — Ampersand Technologies, custom diagnostic insights for precision decision-making and improved outcomes. Point-of-need diagnostic testing for real-time disease detection in agriculture, horticulture, and the environment.
Giving Australian founders access to the education, capital and networks needed to build significant, sustainable, global businesses of the future.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 88
- Round size: Seed $135k–$2.3M; Pre-Seed $125k–$406k
- Lead/follow: 80% lead, 20% follow
- Last fund: Likely still investing — raised $18M in 2021
Portfolio highlights
- Enrola — Looking for online training courses? Discover the perfect course for you with our easy course advisor quiz. Get individual guidance and apply directly.
- Paperly — Paperly helps companies streamline processes, compliance, and approvals in one platform. Gain real-time visibility and empower your teams to work with clarity and confidence.
- Cor — Obi by Cor is the leading voice AI agent for customer onboarding and user activation. It uses voice and on-screen awareness to guide users, share best practices, and answer questions in real time.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Debt Financing
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 80
- Round size: Series A $1.5M–$20M; Debt Financing $1M–$6.7M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $145M in 2022
Portfolio highlights
- me&u — me&u is an online ordering and payment application designed to order meals. They provide communication technology to order and pay through mobile phones at restaurants. Their process of ordering with waiters and splitting bills that enable users to order their food and pay bills through a digital payment platform.
- Truescope — Make better informed communications decisions with Truescope. Harnessing millions of media posts every day to deliver you real-time information that influences your business strategy.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Third Hemisphere is a technology and finance communications firm for innovators and leaders who are breaking new ground.
Show more...Investment focus
- Industry: Aquaculture, Life Science, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Fremantle Seaweed — Fremantle Seaweed is committed to combating climate change by growing Asparagopsis along with a variety of other local seaweeds ocean grown in local Western Australia waters.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Series A $1.3M–$13M; Series B $6.4M–$16M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Paul Little’s family office operates as an investment firm.
Show more...Investment focus
- Industry: E-Commerce, Real Estate, Life Science
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
- EstateXchange — Simplest way to settle deceased estates securely. Save time with estates administration. For lawyers, banks & more. Deliver faster outcomes for all.
Parkview International operates as a single-family office.
Show more...Investment focus
- Industry: Pet, Medical, Veterinary
- Stage:Series A, Series C
- Geography: Australia, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Petfolk — Petfolk's world-class animal hospitals & pet care centers offer virtual, in-person & urgent veterinary care with a pet-parent-focused approach. Learn more!
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 investors investing in Oceania Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!